Holen Sie sich die Stockscreener-App
0.3328
2.12%
-0.0072
Handel nachbörslich:
.33
-0.0028
-0.84%
Schlusskurs vom Vortag:
$0.34
Offen:
$0.3525
24-Stunden-Volumen:
1.53M
Relative Volume:
0.17
Marktkapitalisierung:
$10.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-15.43%
1M Leistung:
-35.75%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.323
$0.3598
1-Wochen-Bereich:
$0.309
$0.4315
52-Wochen-Spanne:
$0.265
$2.22
Profusa Inc Stock (PFSA) Company Profile
Firmenname
Profusa Inc
Sektor
Branche
Telefon
212-494-9022
Adresse
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Vergleichen Sie PFSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.3328 | 12.27M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
136.04 | 234.21B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
97.83 | 145.55B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
376.83 | 144.45B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.08 | 122.61B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.41 | 43.77B | 5.69B | 1.41B | 577.90M | 6.95 |
Profusa Inc Aktie (PFSA) Neueste Nachrichten
Profusa Restructures Securities Agreement for Flexibility - MSN
Profusa Faces Nasdaq Listing Compliance Challenges - MSN
Profusa receives Nasdaq notices for minimum value and bid price compliance - Investing.com
This Penny Stock Is Surging on an Nvidia Boost. Should You Buy Shares Now or Stay Far Away? - Barchart.com
Profusa (PFSA) Stock: Soars 76% on NVIDIA-Powered AI Breakthrough in Biochemistry Monitoring - parameter.io
Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs Power Next-Gen Platform - Yahoo Finance
Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring - GlobeNewswire
Profusa, Inc. Adopts NVIDIA -Powered Technology to Build Ai-Driven Insight Portal for Continuous Biomarker Monitoring - MarketScreener
Profusa’s Risky Vision for High-Tech Medical Sensors - Finimize
Profusa Approves $100 Million Equity Line of Credit - MSN
Profusa shareholders approve $100 million equity line of credit with Ascent Partners By Investing.com - Investing.com South Africa
Profusa shareholders approve $100 million equity line of credit with Ascent Partners - Investing.com Australia
Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base - GlobeNewswire
300+ CLTI Patients Annually: Profusa's Oxygen Monitoring Tech Enters Major Belgian Hospital - Stock Titan
Profusa's Strategic Position in Digital Health Innovation - AInvest
Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Digital Health Pioneer Profusa to Showcase Continuous Biochemistry Monitoring Tech at Major Conference - Stock Titan
Profusa announces commercial and clinical collaboration with head of angiography, Medical University of Graz, Austria - MarketScreener
Profusa Announces Commercial and Clinical Collaboration - GlobeNewswire
Leading Vascular Center Adopts Profusa's Real-Time Oxygen Monitoring Tech for 1,500 Annual Procedures - Stock Titan
Profusa amends purchase agreement and note terms for convertible debt tranches - Investing.com Australia
Profusa Restructures Securities Agreement for Enhanced Flexibility - AInvest
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket - Benzinga
Profusa Appoints New CFO and Lead Director - TipRanks
Profusa, Inc. shares fall 8.88% intraday despite adding seasoned finance executive Fred Knechtel as CFO. - AInvest
Profusa adds former VA chief and Fortune 500 executive to leadership - Investing.com
Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O’Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO - The Manila Times
Profusa Welcomes Former Acting U.S. Veterans Affairs - GlobeNewswire
Profusa, Inc. Appoints Fred Knechtel as CFO - MarketScreener
Profusa, Inc. shares rise 4.26% premarket after announcing a distributor for its tissue oxygen technology. - AInvest
Profusa Inc (NASDAQ: PFSA) Establishes a distributor partner in Spain for Lumee Oxygen platform - MarketScreener
Profusa announces initial $1 million bitcoin investment to initiate its digital asset treasury strategy - MSN
Profusa, Inc. SEC 10-Q Report - TradingView
Profusa Announces Nasdaq Listing and Growth Plans - TipRanks
Strategic partnerships have been essential to Profusa’s progress: CEO Ben Hwang - AlphaStreet
Profusa shares strategy update as it transitions to public company By Investing.com - Investing.com South Africa
Profusa shares strategy update as it transitions to public company - Investing.com India
Profusa, Inc. Outlines Growth Strategy and Milestones in Shareholder Letter Following Nasdaq Listing - Quiver Quantitative
Profusa Achieves Milestones, Commits to Groundbreaking Biochemistry Tech. - AInvest
Profusa, Inc. Provides Strategy Overview and Business Update for Investors - Bluefield Daily Telegraph
Profusa Reports Q1 2026 Commercial Launch in Europe for Tissue Oxygen Monitoring Platform - AInvest
Finanzdaten der Profusa Inc-Aktie (PFSA)
Es liegen keine Finanzdaten für Profusa Inc (PFSA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):